Sagent Turns Generic Injectable Shortages Into Business Opportunity
This article was originally published in The Pink Sheet Daily
Executive Summary
The specialty generic manufacturer has a facility dedicated to producing shortage drugs, a seemingly endless commercial opportunity given the development, regulatory and reimbursement challenges in the sterile injectable space.